Search results
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 13 hours agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...
Should You Buy Moderna Before May 12?
Motley Fool via Yahoo Finance· 6 days agoThe biotech company aims to bring as many as 15 new products to market over the next five years and has the late-stage pipeline to support...is set to...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks via Yahoo Finance· 14 hours agoSI&A spending is expected in the range of $13...billion to $14.8 billion. The adjusted tax rate is...
On doorstep of approval, Merck compares V116 pneumococcal vaccine to 1983 warhorse Pneumovax 23
FierceBiotech· 3 days agoFive months ago, Merck revealed data that indicate its next-generation pneumococcal vaccine offers more protection for older adults than Pfizer’s market dominator Prevnar ...
Health Care Roundup: Market Talk
The Wall Street Journal· 13 hours agoRead about GSK and Haleon in the latest Market Talks covering the Health Care sector.
FDA Says Vaccination Is the Best Protection Against Measles
Sierra Sun Times· 3 days agoMeasles is one of the most contagious respiratory diseases in the world that has the potential to be life-threatening. Vaccines approved by the U.S. Food and Drug Administration ...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 7 days agoQuarter in Detail The Pharmaceutical segment generated revenues of $14.0 billion, up 9% year over...
Biotech Stocks Facing FDA Decision In May 2024
RTT News· 2 days agoAs April comes to an end, attention shifts to biotech stocks poised for regulatory events in May. The FDA approved eight novel drugs last May, contributing to a total of 55 approvals ...
Pfizer lifts profit forecast as CEO sees reason for optimism in 2024
Reuters via Yahoo Finance· 19 hours ago(Reuters) -Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter...
First-in-class IL-15 receptor agonist nabs FDA approval for bladder cancer
Nature· 6 days agoDiscover the world’s best science and medicine | Nature.com